NCCN publishes first-ever treatment recommendations pertaining to neuroblastoma

The National Comprehensive Cancer Network (NCCN)-;an alliance of leading cancer centers-;today published its first ever set of treatment recommendations pertaining to neuroblastoma.

Novel Doublet Highly Effective in Low-Grade Serous Ovarian Cancer

The investigational combination of avutometinib (a dual RAF/MEK inhibitor) and defactinib (a FAK inhibitor) achieved very high response rates in heavily pretreated patients with recurrent

December 6, 2023

Unlocking vitamin B6’s role in pancreatic cancer and immune system battle

Vitamin B6 is beneficial in many ways, notably for its role in maintaining a strong immune system. However, when pancreatic cancer develops, its cells also

February 24, 2024

Can gene therapies make for a profitable business? Keep your eye on Bluebird Bio

Happy Groundhog Day eve. Some takes and thoughts on Bluebird Bio’s quest for gene therapy profits, a reality check on Vertex’s highly touted pain drug,

February 1, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.